drugset / Trial / NCT06161805
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this randomized controlled trial is to investigate the effect of esketamine versus placebo on the NRS score for chronic pelvic pain. Secondary endpoints are to assess pain scores, side-effects, quality of life, depressive symptoms and pain coping.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2026-01-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.5 mg/kg | Other |